Previous 10 | Next 10 |
T2 Biosystems is generating strong sales growth for its sepsis diagnostics testing products. The company's proprietary technology offers clinical advantages to traditional blood testing methods supporting a positive long-term outlook. We are bullish on the stock which has several ...
The price of shares of in vitro diagnostic specialist T2 Biosystems (TTOO) soared after the company confirmed that its T2SARS-CoV-2 Panel can detect different COVID-19 strains. However, given the COVID-19 diagnostic testing industry’s competitive landscape, will the company be able to ...
Are These Biotech Penny Stocks Worth Watching in 2021? Biotech penny stocks are without a doubt, some of the biggest winners of the year. While this began as a result of the pandemic, Covid has helped to push biotech companies regardless of their work relating to it. So on one hand,...
4 Biotech Penny Stocks to Watch Right Now As you put together a penny stock watchlist for the month of June you might want to keep in mind what news could come out during the month. The biotech industry is well-known for releasing news often. This can occur prior to a new compounds roll...
4 Biotech Penny Stocks for Your June Watchlist When considering penny stocks this upcoming month, it’s important to look at ones with recent news, upcoming products, or future growth predictions. In the past year, biotech penny stocks have continued to perform quite well. And...
LEXINGTON, Mass., May 25, 2021 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, today reminded stockholders to vote at the upcoming 2021 Annual Meeting of Stockholders to be held on June 25, 2021. The T2 Biosystems Boar...
Top Penny Stocks That Could Benefit From Events This Year Investing in penny stocks is an art. It’s not for everyone, and it’s definitely not for the faint of heart. However, if you can master it, the potential is unlimited. So, when it comes to making a list of penny st...
iBio (IBIO) +33% on COVID-19 study update.Orgenesis (ORGS) +11% on Q1 results.Chemomab Therapeutics (CMMB) +12%.T2 Biosystems, Inc. (TTOO) +11% on Q1 results.ViewRay (VRAY) +12%.Epizyme (EPZM) +11% on Q1 results.CureVac N.V. (CVAC) +9%.Roku (ROKU) +9% on Q1 results.Da...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Good morning and get ready to take a break and unwind over the weekend. But don’t take off the suit and tie just yet! There’s still got one more busy day of trading to get through and we’re here to help...
T2 Biosystems, Inc. (TTOO) Q1 2021 Earnings Conference Call May 06, 2021, 04:30 PM ET Company Participants Philip Taylor - Investor Relations, Gilmartin Group John Sperzel - President and Chief Executive Officer John Sprague - Chief Financial Officer Conference Call Participants Stephanie Yan...
News, Short Squeeze, Breakout and More Instantly...
LEXINGTON, Mass., April 24, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, announced today that it will report financial results for the first quarter 2024 and business updates after mar...
Shares of Nucor Corporation (NYSE:NUE) fell sharply during Tuesday's session after the company reported worse-than-expected quarterly financia...
Shares of Hibbett, Inc. (NASDAQ:HIBB) rose sharply in today's pre-market trading after the company agreed to be acquired by JD Sports Fashion ...